Nephron-sparing surgery for small-to-medium sized renal tumors has undoubtedly become a standard of patient management in the 21 st century. The recent trends toward nephron sparing stem from an ...

A study presented at the Society of Interventional Radiology’s 37th Annual Scientific Meeting in San Francisco, Calif. shows that percutaneous cryoablation may be provide another treatment alternative ...

Two new studies support an expansion of the role of percutaneous cryoablation in the management of renal masses. The use of ablative techniques was originally restricted to those patients harboring ...

Overall and disease-free survival was nearly 100% after a median follow-up of one year, study shows. SAN DIEGO—Percutaneous cryoablation for renal cell carcinoma is a safe modality that carries ...

There is great interest in evaluating the link between hypercalcemia and prognosis in ccRCC by researching the genes that influence calcium levels. No residual malignancy was found in 98% of patients ...

Introduction: The widespread use of ultrasound and cross-sectional imaging has led to a steady increase in the incidental discovery of renal masses. Most of them are treated with partial nephrectomy ...

Atrial fibrillation is the irregular and rapid beating of the upper two chambers of the heart (the atria). This is caused by the disorganisation of the electrical impulses that control the heartbeat ...

Feasibility study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage II-IIIA non-small cell lung cancer. Background: Percutaneous cryoablation for lung tumors ...

Racial and gender disparities in renal cell carcinoma. The effects of HDIL-2 in combination with pazopanib or sunitinib on PBMCs’ function and RCC cells’ apoptosis: Preliminary in vitro data.

CAESAREA, Israel, Oct. 7, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that ...

"These peer-reviewed publications further advance ProSense®'s clinical validation," stated IceCure's Chief Executive Officer, Eyal Shamir. "In the THERMAC Trial, ProSense® cryoablation outperformed ...

Current evidence on the efficacy and safety of percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillation is adequate to support the use of this procedure provided that ...